BURLINGTON, Mass., Oct. 25, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum at the Westin Grand Central in New York, NY, on Thursday, November 14, 2013. George W. LeMaitre, Chairman & CEO, will provide an update on the Company at 3:00 pm EST.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com .LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
CONTACT: LeMaitre Vascular, Inc. Mary Nielson +1-781-425-1659 firstname.lastname@example.org http://www.lemaitre.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts